Tanabe Pharma Corporation

This study tested a new medication called MP-214 in 34 adults with schizophrenia. Participants took the pill once daily for 14 days to see if it was safe and how well it worked. The goal was to find the right dose and check for side effects.

This study tested a drug called MCI-186 (edaravone) in 181 people with ALS, a serious nerve disease that weakens muscles. Participants received the drug or a placebo over 24 weeks to see if it could slow the disease's progress. The goal was to measure changes in daily function an…

This early-stage study tested a single dose of MT-2990 in 75 adults with Japanese cedar pollen allergy. Researchers checked safety, how the drug moves through the body, and whether it eases nasal symptoms in a controlled pollen chamber. The goal is to see if MT-2990 could become …

This study tested a medicine called TAU-284 in 490 children aged 7 to 15 who have year-round nasal allergies. The goal was to see if it reduces sneezing, runny nose, and stuffiness better than a placebo. The medicine was given for two weeks, and researchers also checked for side …

This study looked at whether an oral suspension (liquid taken by mouth) of edaravone works the same as the intravenous (IV) form given through a vein. It involved 42 healthy Japanese adults aged 20 to 45. The goal was to measure how much of the drug gets into the blood and how fa…

This early-stage study tested the safety and how the body processes a new drug called MT-7117 in 40 healthy Chinese adults aged 18 to 55. Participants received either the drug or a placebo, and researchers measured drug levels in the blood and monitored for side effects. The goal…